News Story: Full Text
Sponsored By
AbbVie
Please Click On The Above Banner For More Details
Braintumor Website

 

H3 K27M-mutant gliomas in adults vs. children share similar histological features and adverse prognosis.

Al's Comment:

 This mutation is a bad sign if present.  Most DIPG patients have it, and some GBM patients have it.  Average survival in an adult Glioblastoma is usually less than half as long as those without it.  Luckily, there are a few treatments in the pipeline that target this mutation.   ONC201 is one of them - it is in trials for both adult and pediatric brain tumors with this mutation.  Too early to tell how it will work but I do know of a few people who did well with it.  If you have this mutation but do not fit any of the trials, there may be other ways of getting it. Contact us for help.


Posted on: 02/03/2018

H3 K27M-mutant gliomas in adults vs. children share similar histological features and adverse prognosis.

 


Click HERE to return to brain tumor news headlines


Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2018 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740


Website Design By
World Wide Websites



Musella Foundation For Brain Tumor Research & Information, Inc